Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test

2019 
AbstractNeprilisin and angiotensin receptor inhibition (Sacubitril/Valsartan, i.e. ARNI) is recommended in heart failure guidelines for patients in NYHA class II-III with reduced left ventricular e...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    21
    References
    11
    Citations
    NaN
    KQI
    []